Signs & Symptoms Clinical presentation varies significantly by diabetes type, duration, and degree of glycemic control
Current laboratory, animal, and early clinical research is encouraging and has not identified a consistent pattern of serious adverse events
Nausea (most common, especially during first 1 to 2 weeks of a new dose) Diarrhea or, just as often, constipation Vomiting (less common but more likely at 9 to 12 mg) Reduced appetite, food noise quieting down (this is the goal, not a side effect) Skin sensitivity (dysesthesia): tingling, prickly feeling, or sunburn-like skin
This review focuses on the relationship between gut microbiota, MGBA, and RT, highlighting the microbiota's potential to influence RT-induced neural and intestinal side effects
Moreover, the entire plasma -tocopherol pool is replaced daily because of the continued re-secretion from the liver of VLDL containing -tocopherol (15)
It is important to recognize that while the disease affects the SN neurons and cause the classical symptoms, other brain regions, such as respiratory nuclei, also undergo degeneration